Cargando…
Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
BACKGROUND: Data exists to support a mortality reduction from S. aureus bacteremia with adherence to evidence-based recommendations. Therefore, our Antimicrobial Stewardship Team instituted a guideline focused on S. aureus bacteremia management. This study outlines improvements achieved through the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631518/ http://dx.doi.org/10.1093/ofid/ofx163.1276 |
_version_ | 1783269493096579072 |
---|---|
author | Gregory, Eric Wallace, Katie Burgess, Donna R Schadler, Aric Burgess, David S |
author_facet | Gregory, Eric Wallace, Katie Burgess, Donna R Schadler, Aric Burgess, David S |
author_sort | Gregory, Eric |
collection | PubMed |
description | BACKGROUND: Data exists to support a mortality reduction from S. aureus bacteremia with adherence to evidence-based recommendations. Therefore, our Antimicrobial Stewardship Team instituted a guideline focused on S. aureus bacteremia management. This study outlines improvements achieved through the implementation at an academic medical center. METHODS: A quasi-experimental approach evaluated pre-implementation (2014–15) and post-implementation (2015–17) periods. The Antimicrobial Stewardship Team provided a detailed standardized note and management guidelines. Adult patients with S. aureus bacteremia identified by a rapid diagnostic system were evaluated. Patients were excluded if discharged within 48 hours of a first positive blood culture or transitioned to comfort care. The primary outcome was all-cause 30-day mortality and secondary outcomes were total guideline adherence (TGA) and appropriateness of therapy. RESULTS: Overall, 263 patients (105 pre-implementation; 158 post-implementation) were included. No significant differences were observed in baseline characteristics (e.g., age, gender, ethnicity); however, the mean Pitt Bacteremia score was significantly lower in the post-implementation group (2 vs. 1; P = 0.01). Although no difference was observed in all-cause 30-day mortality (13% vs. 15%; P = 0.8), improved TGA (29% vs. 44%; P = 0.01) and appropriateness of therapy (68% vs. 74%; P = 0.26) were noted while duration of bacteremia decreased (3.6 days vs. 2.8 days; P = 0.02) in the post-implementation period. In uncomplicated bacteremia, TGA (15% vs. 38%; P = 0.02) and adequate duration of therapy (54% vs. 77%; P = 0.02) significantly improved. In complicated bacteremia, TGA (36% vs. 48%; P = 0.14) and targeted agents utilized (92% vs. 100%; P < 0.01) increased post-implementation. Additionally, achieving TGA significantly reduced all-cause 30-day mortality in complicated (33% vs. 1.5%; P < 0.01) and uncomplicated (26% vs. 5.6%; P = 0.01) bacteremia for the entire sample. CONCLUSION: The Antimicrobial Stewardship initiative significantly improved adherence to evidence-based guidelines for S. aureus bacteremia management. Though no impact on all-cause mortality was observed, a significant effect was noted when TGA was achieved. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5631518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56315182017-11-07 Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia Gregory, Eric Wallace, Katie Burgess, Donna R Schadler, Aric Burgess, David S Open Forum Infect Dis Abstracts BACKGROUND: Data exists to support a mortality reduction from S. aureus bacteremia with adherence to evidence-based recommendations. Therefore, our Antimicrobial Stewardship Team instituted a guideline focused on S. aureus bacteremia management. This study outlines improvements achieved through the implementation at an academic medical center. METHODS: A quasi-experimental approach evaluated pre-implementation (2014–15) and post-implementation (2015–17) periods. The Antimicrobial Stewardship Team provided a detailed standardized note and management guidelines. Adult patients with S. aureus bacteremia identified by a rapid diagnostic system were evaluated. Patients were excluded if discharged within 48 hours of a first positive blood culture or transitioned to comfort care. The primary outcome was all-cause 30-day mortality and secondary outcomes were total guideline adherence (TGA) and appropriateness of therapy. RESULTS: Overall, 263 patients (105 pre-implementation; 158 post-implementation) were included. No significant differences were observed in baseline characteristics (e.g., age, gender, ethnicity); however, the mean Pitt Bacteremia score was significantly lower in the post-implementation group (2 vs. 1; P = 0.01). Although no difference was observed in all-cause 30-day mortality (13% vs. 15%; P = 0.8), improved TGA (29% vs. 44%; P = 0.01) and appropriateness of therapy (68% vs. 74%; P = 0.26) were noted while duration of bacteremia decreased (3.6 days vs. 2.8 days; P = 0.02) in the post-implementation period. In uncomplicated bacteremia, TGA (15% vs. 38%; P = 0.02) and adequate duration of therapy (54% vs. 77%; P = 0.02) significantly improved. In complicated bacteremia, TGA (36% vs. 48%; P = 0.14) and targeted agents utilized (92% vs. 100%; P < 0.01) increased post-implementation. Additionally, achieving TGA significantly reduced all-cause 30-day mortality in complicated (33% vs. 1.5%; P < 0.01) and uncomplicated (26% vs. 5.6%; P = 0.01) bacteremia for the entire sample. CONCLUSION: The Antimicrobial Stewardship initiative significantly improved adherence to evidence-based guidelines for S. aureus bacteremia management. Though no impact on all-cause mortality was observed, a significant effect was noted when TGA was achieved. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631518/ http://dx.doi.org/10.1093/ofid/ofx163.1276 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Gregory, Eric Wallace, Katie Burgess, Donna R Schadler, Aric Burgess, David S Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title | Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title_full | Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title_fullStr | Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title_full_unstemmed | Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title_short | Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia |
title_sort | impact of an antimicrobial stewardship initiative focused on staphylococcus aureus bacteremia |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631518/ http://dx.doi.org/10.1093/ofid/ofx163.1276 |
work_keys_str_mv | AT gregoryeric impactofanantimicrobialstewardshipinitiativefocusedonstaphylococcusaureusbacteremia AT wallacekatie impactofanantimicrobialstewardshipinitiativefocusedonstaphylococcusaureusbacteremia AT burgessdonnar impactofanantimicrobialstewardshipinitiativefocusedonstaphylococcusaureusbacteremia AT schadleraric impactofanantimicrobialstewardshipinitiativefocusedonstaphylococcusaureusbacteremia AT burgessdavids impactofanantimicrobialstewardshipinitiativefocusedonstaphylococcusaureusbacteremia |